BCAA

BCAAs — branched-chain amino acids — are three of the nine essential amino acids your body can't make and must get from food: leucine, isoleucine, and valine. They're "branched-chain" because of their molecular shape, and they're sold as a supplement (almost always in a 2:1:1 leucine-to-isoleucine-to-valine ratio) on the premise that they drive muscle growth and recovery. Of the three, leucine is the star: it's the amino acid that acts as the trigger signal for muscle protein synthesis.

Here's the part the supplement industry skips. BCAAs are only THREE of the nine essential amino acids, and building new muscle protein requires all nine. You can think of leucine as the light switch that turns the muscle-building machinery ON — but the machinery still needs the full set of amino-acid "bricks" to actually build with. Supply only leucine, isoleucine, and valine, and the other six essential aminos become the bottleneck. That's why isolated BCAAs produce a real but submaximal effect: in a controlled trial, BCAAs alone raised muscle protein synthesis about 22% over a placebo (Jackman 2017, PMID 28638350) — meaningfully less than intact protein produces — and a major review concluded the claim that BCAAs alone meaningfully build muscle in humans is "unwarranted" (Wolfe 2017, PMID 28852372).

Which leads to the single most important, most honest thing to understand about BCAAs: if you already eat enough complete protein, they add very little. Roughly 1.6 g of protein per kilogram of bodyweight per day, with 25-40 g of protein at each meal, already delivers both the leucine trigger AND the complete amino pool. In that situation a BCAA scoop is largely redundant — a whey shake, a full-spectrum EAA, or simply a protein-rich meal does everything a BCAA tub does and supplies the missing six aminos too. BCAAs aren't useless; they're just a narrow tool that most well-fed lifters don't need for growth.

Leucine is the active trigger. It activates a cellular pathway called mTORC1, the master regulator that switches on muscle protein synthesis. Cross a leucine threshold of roughly 2-3 g in a serving and you flip that switch — which is why a real 2:1:1 BCAA dose (about 2.5-4 g leucine) does measurably raise muscle protein synthesis after training (Jackman 2017, PMID 28638350; Blomstrand 2006, PMID 16365096, showed BCAAs activate the relevant signaling enzymes including mTOR and p70 S6 kinase post-exercise).

But flipping the switch isn't the same as finishing the build, and this is where the evidence gets honest about isolated BCAAs. When researchers compared amino-acid formulations head-to-head after resistance exercise, mTORC1 activation ranked clearly: leucine alone < BCAAs < all nine essential amino acids (Moberg 2016, PMID 27053525). Adding the other six EAAs produced a stronger, more sustained anabolic signal — because the muscle could both START synthesis (leucine) and COMPLETE it (the full amino pool). This is the mechanistic reason a complete protein or a full-spectrum EAA outperforms a BCAA-only product for muscle growth, and why we rank an EAA (Thorne Amino Complex) inside the top three of the BCAA listicle.

Where BCAAs do earn a defined role: recovery and endurance, not maximal growth. Around damaging exercise, BCAA supplementation has been shown to modestly reduce muscle soreness and improve some recovery markers (VanDusseldorp 2018, PMID 30275356), though a systematic review found the effect is inconsistent and largest when muscle damage is high and habitual protein intake is low (Fouré & Bendahan 2017, PMID 28934166). For endurance athletes, BCAAs may also blunt "central fatigue" — by competing with tryptophan for transport into the brain, they can reduce exercise-induced serotonin that contributes to the feeling of tiredness. So the accurate mechanism story is: a real leucine trigger and a modest, condition-dependent recovery aid — useful intra-workout, during fasted training, and for endurance sessions, but not a substitute for the complete protein that actually builds muscle.